Skip to menu Skip to content Skip to footer

2024

Conference Publication

A community-based MASLD care pathway for people with type 2 diabetes: barriers and considerations

Aikebuse, Melanie, Gracen, Lucy, Sarraf, Babak, Mcphail, Steven, Russell, Anthony, O'Beirne, James, Irvine, Katharine, Williams, Suzanne, Valery, Patricia and Powell, Elizabeth (2024). A community-based MASLD care pathway for people with type 2 diabetes: barriers and considerations. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons.

A community-based MASLD care pathway for people with type 2 diabetes: barriers and considerations

2024

Conference Publication

qBallooning: AI-based ballooned hepatocyte detection and quantification by second harmonic generation/two photon excitation microscopy

Kleiner, David E., Clouston, Andrew D., Goodman, Zachary, Guy, Cynthia D., Brunt, Elizabeth M., Lackner, Carolin, Tiniakos, Dina G., Wee, Aileen, Yeh, Matthew, Leow, Wei Qiang, Chng, Elaine, Ren, Yayun, Goh, George Boon Bee, Powell, Elizabeth E., Rinella, Mary E., Sanyal, Arun J, Neuschwander-Tetri, Brent A., Younossi, Zobair, Charlton, Michael, Ratziu, Vlad, Harrison, Stephen A., Tai, Dean and Anstee, Quentin M. (2024). qBallooning: AI-based ballooned hepatocyte detection and quantification by second harmonic generation/two photon excitation microscopy. EASL Congress 2024, Milan, Italy, 5-8 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0168-8278(24)01444-2

qBallooning: AI-based ballooned hepatocyte detection and quantification by second harmonic generation/two photon excitation microscopy

2023

Conference Publication

Potentially inappropriate medicine’ use and nonadherence in hepatic encephalopathy: a retrospective real-world cohort study

Hong, Zhen Howe, Johnson, Stephanie, Ha, Tina, McIvor, Carolyn, Stuart, Katherine, Valery, Patricia, Powell, Elizabeth and Hayward, Kelly (2023). Potentially inappropriate medicine’ use and nonadherence in hepatic encephalopathy: a retrospective real-world cohort study. EASL Congress 2023, Vienna, Austria, 21 - 24 June 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0168-8278(23)00794-8

Potentially inappropriate medicine’ use and nonadherence in hepatic encephalopathy: a retrospective real-world cohort study

2023

Conference Publication

DESCRIPTIVE ANALYSIS OF OBSTETRIC PATIENTS WITH PULMONARY EMBOLISM AT A SINGLE TERTIARY CENTER

Lankford, Allison, Gerding, James, Jones, Kevin, Cires-Drouet, Rafael, Tran, Quincy, Haase, Daniel, Nagarsheth, Khanjan, Naselsky, Warren, Jayanathan, Mark, Drummond, Rosa and Powell, Elizabeth (2023). DESCRIPTIVE ANALYSIS OF OBSTETRIC PATIENTS WITH PULMONARY EMBOLISM AT A SINGLE TERTIARY CENTER. 52nd Critical Care Congress of the Society-of-Critical-Care-Medicine (SCCM), San Francisco Ca, Jan 21-24, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

DESCRIPTIVE ANALYSIS OF OBSTETRIC PATIENTS WITH PULMONARY EMBOLISM AT A SINGLE TERTIARY CENTER

2023

Conference Publication

IS IT SAFE TO BE DISCHARGED FROM THE RESUSCITATION CRITICAL CARE UNIT? A LONGITUDINAL ASSESSMENT

Haase, Daniel, Widjaja, Austin, Aquino, Alexa, Aligabi, Ayah, Bzhilyanskaya, Vera, Epstein, Jacob, Faisal, Manal, Kowansky, Taylor, Lin, Yiting, Okolo, Robinson, Plotnikova, Anya, Quackenbush, Jane, Sahadzic, Iana, Singh, Aditi, Tang, Kaitlyn, Yardi, Isha, Niles, Erin, Hart, Emily, Powell, Elizabeth and Tran, Quincy (2023). IS IT SAFE TO BE DISCHARGED FROM THE RESUSCITATION CRITICAL CARE UNIT? A LONGITUDINAL ASSESSMENT. 52nd Critical Care Congress of the Society-of-Critical-Care-Medicine (SCCM), San Francisco Ca, Jan 21-24, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

IS IT SAFE TO BE DISCHARGED FROM THE RESUSCITATION CRITICAL CARE UNIT? A LONGITUDINAL ASSESSMENT

2023

Conference Publication

PROLONGED UNCONSCIOUSNESS IN SEVERE COVID-19 PNEUMONIA WITH VENOVENOUS ECMO SUPPORT

Ramadan, Leena, Shi, Tesia, Esposito, Emily, Powell, Elizabeth, Tran, Quincy, Motta, Melissa, Scalea, Thomas and Tabatabai, Ali (2023). PROLONGED UNCONSCIOUSNESS IN SEVERE COVID-19 PNEUMONIA WITH VENOVENOUS ECMO SUPPORT. 52nd Critical Care Congress of the Society-of-Critical-Care-Medicine (SCCM), San Francisco Ca, Jan 21-24, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

PROLONGED UNCONSCIOUSNESS IN SEVERE COVID-19 PNEUMONIA WITH VENOVENOUS ECMO SUPPORT

2022

Conference Publication

Non-alcoholic fatty liver disease and type 2 diabetes: low referral rate of patients at increased risk of progressive liver disease

Gracen, Lucy, Hayward, Kelly, Aikebuse, Melanie, Russell, Anthony, O'Beirne, James, Irvine, Katharine, Williams, Suzanne, Valery, Patricia and Powell, Elizabeth (2022). Non-alcoholic fatty liver disease and type 2 diabetes: low referral rate of patients at increased risk of progressive liver disease. AMSTERDAM: ELSEVIER.

Non-alcoholic fatty liver disease and type 2 diabetes: low referral rate of patients at increased risk of progressive liver disease

2021

Conference Publication

BACTERAEMIA, SEPSIS, AND ANTIBIOTIC RESISTANCE IN AUSTRALIAN PATIENTS WITH CIRRHOSIS: A POPULATION-BASED STUDY

Johnson, Amy, Ratnasekera, Isanka, Irvine, Katharine, Henderson, Andrew, Powell, Elizabeth and Valery, Patricia (2021). BACTERAEMIA, SEPSIS, AND ANTIBIOTIC RESISTANCE IN AUSTRALIAN PATIENTS WITH CIRRHOSIS: A POPULATION-BASED STUDY. Annual Meeting of the British-Society-of-Gastroenterology (BSG), Electr Network, Nov 08-12, 2021. LONDON: BMJ PUBLISHING GROUP. doi: 10.1136/gutjnl-2021-BSG.235

BACTERAEMIA, SEPSIS, AND ANTIBIOTIC RESISTANCE IN AUSTRALIAN PATIENTS WITH CIRRHOSIS: A POPULATION-BASED STUDY

2019

Conference Publication

A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLD

McKillen, B., Elangovan, H., Horsfall, L., Patel, P., Hayward, K., Clouston, A., Radford-Smith, D., Valery, P., Britton, L., Brown, N., Bernard, A. and Powell, E. (2019). A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLD. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, SA Australia, 8–10 September 2019. Richmond, VIC Australia: Wiley-Blackwell.

A time-dependent analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score and Fibrosis-4 score in patients with NAFLD

2019

Conference Publication

Health-related quality of life in patients with cirrhosis

Amarasena, S., Bernardes, C., Stuart, K., Gupta, R., Horsfall, L., Rahman, T., Clark, P., Skoien, R., Hartel, G., Hayward, K., Powell, E. and Valery, P. (2019). Health-related quality of life in patients with cirrhosis. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2020, Online, 21–30 November 2020. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/jgh.15269

Health-related quality of life in patients with cirrhosis

2019

Conference Publication

Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation

Iyer, Abishek, Loh, Zhixuan, Fitzsimmons, Rebecca L., Reid, Robert C., Ramnath, Divya, Clouston, Andrew, Irvine, Katharine M., Powell, Elizabeth E., Schroder, Kate, Stow, Jennifer L., Sweet, Matthew J. and Fairlie, David P. (2019). Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation. Experimental Biology Meeting (EB), Orlando Fl, Apr 06-09, 2019. HOBOKEN: WILEY.

Histone Deacetylase Inhibitors Attenuate Hepatic Fibrosis through Suppression of Group 2 Innate Lymphoid Cells and Type 2 Inflammation

2018

Conference Publication

Advanced fibrosis is associated with longitudinal increases in Fibrosis-4 and NAFLD fibrosis scores

Patel, Preya, Cheng, Johnson Chieh-Yu, Banh, Xuan, Hossain, Fabrina, Horsfall, Leigh Ula, Hayward, Kelly Lee, Williams, Suzanne, Johnson, Tracey, Brown, Nigel Neil, Saad, Nivene, Stuart, Katherine A., Russell, Anthony William, Valery, Patricia Casarolli, Irvine, Katharine, Clouston, Andrew D., Bernard, Anne and Powell, Elizabeth E. (2018). Advanced fibrosis is associated with longitudinal increases in Fibrosis-4 and NAFLD fibrosis scores. Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) / Liver Meeting, San Francisco, CA United States, 9-13 November 2018. Hoboken, NJ United States: John Wiley & Sons. doi: 10.1002/hep.30257

Advanced fibrosis is associated with longitudinal increases in Fibrosis-4 and NAFLD fibrosis scores

2017

Conference Publication

Can modest alcohol intake be dismissed as a co-factor in diabetic patients with non-alcoholic fatty liver disease?

Patel, P. J., Smith, D. D., Stuart, K. A., Horsfall, L. U., Hayward, K. L., Hossain, F., Williams, S., Johnson, T., Brown, N. N., Saad, N., Clouston, A. D., Irvine, K. M., Russell, A. W., Valery, P. C. and Powell, E. E. (2017). Can modest alcohol intake be dismissed as a co-factor in diabetic patients with non-alcoholic fatty liver disease?. International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, Netherlands, 19-23 April 2017. Amsterdam, Netherlands: Elsevier. doi: 10.1016/S0168-8278(17)31602-1

Can modest alcohol intake be dismissed as a co-factor in diabetic patients with non-alcoholic fatty liver disease?

2017

Conference Publication

Enhanced Liver Fibrosis test and liver stiffness measurements identify high prevalence of advanced fibrosis in people with type 2 diabetes

Patel, P. J., Stuart, K. A., Horsfall, L. U., Hayward, K. L., Hossain, F., Williams, S., Johnson, T., Brown, N., Lampe, G., Buck, L., Saad, N., Clouston, A., Irvine, K. M., Russell, A., Valery, P. C. and Powell, E. E. (2017). Enhanced Liver Fibrosis test and liver stiffness measurements identify high prevalence of advanced fibrosis in people with type 2 diabetes. Gastroenterological Society of Australia Australian Gastroenterology Week Precision Medicine in Gastroenterology, Gold Coast, QLD Australia, 20 - 22 August 2017. Richmond, VIC Australia: Wiley-Blackwell.

Enhanced Liver Fibrosis test and liver stiffness measurements identify high prevalence of advanced fibrosis in people with type 2 diabetes

2016

Conference Publication

Non-invasive markers indicate a high prevalence of advanced fibrosis in adults with type 2 diabetes

Patel, P. J., Stuart, K. A., Horsfall, L. U., Hossain, F., Williams, S., Johnson, T., Brown, N., Lampe, G., Buck, L., Clouston, A., Irvine, K. M., Russell, A. and Powell, E. E. (2016). Non-invasive markers indicate a high prevalence of advanced fibrosis in adults with type 2 diabetes. Gastroenterological Society of Australia, Australian Gastroenterology Week 2016, Adelaide, South Australia, Australia, 10–12 October, 2016. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.13520

Non-invasive markers indicate a high prevalence of advanced fibrosis in adults with type 2 diabetes

2016

Conference Publication

Medication adherence in outpatients with decompensated cirrhosis

Hayward, K. L., Cottrell, W. N., Karmakar, A., Patel, P. J., Horsfall, L. U., Martin, J. H., Irvine, K. M., Tallis, C. J., Wright, P. L., Stuart, K. A., Valery, P. C. and Powell, E. E. (2016). Medication adherence in outpatients with decompensated cirrhosis. Gastroenterological Society of Australia, Australian Gastroenterology Week 2016, Adelaide, SA Australia, 10–12 October 2016. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/jgh.13520

Medication adherence in outpatients with decompensated cirrhosis

2015

Conference Publication

An exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia

Valery, P. C., Clark, P. J., Mcphail, S. M., Martin, J., Horsfall, L., Volk, M. L. and Powell, E. (2015). An exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia. HOBOKEN: WILEY-BLACKWELL.

An exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia

2015

Conference Publication

Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activation

Irvine, K. M., Clouston, A. D., Blumenthal, A. and Powell, E. E. (2015). Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activation. GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week, Brisbane, QLD, Australia, 28 September - 2 October 2015. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/jgh.13087

Blocking Wnt protein secretion from macrophages exacerbates liver fibrosis and hepatic progenitor cell activation

2015

Conference Publication

Deletion of Wntless in macrophages exacerbates liver fibrosis and the ductular reaction in chronic liver injury

Irvine, Katharine, Clouston, Andrew D., Blumenthal, Antje and Powell, Elizabeth E. (2015). Deletion of Wntless in macrophages exacerbates liver fibrosis and the ductular reaction in chronic liver injury. 66th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), San Francisco, United States, Nov 13-17, 2015. Hoboken, United States: John Wiley & Sons.

Deletion of Wntless in macrophages exacerbates liver fibrosis and the ductular reaction in chronic liver injury

2015

Conference Publication

Discrepancies in the use of medications in patients with cirrhosis

Hayward, K., Valery, P. C., Cottrell, N., Irvine, K., Horsfall, L., Ruffin, B., Tallis, C., Chachay, V., Martin, J. and Powell, E. (2015). Discrepancies in the use of medications in patients with cirrhosis. GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week, Brisbane, QLD Australia, 28 September - 2 October 2015. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1111/jgh.13093

Discrepancies in the use of medications in patients with cirrhosis